MM-508 Belantamab Mafodotin for Relapsed or Refractory Multiple Myeloma: A Real-World Observational Study Update
Clinical Lymphoma, Myeloma & Leukemia（2023）
Key words
multiple myeloma,relapsed/refractory multiple myeloma,real-world evidence,belantamab mafodotin
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined